Page 17 - 《中国药房》2024年8期
P. 17
nel” management policies of nationally negotiated drugs 模式研究[J]. 世界临床药物,2021,42(9):734-740.
in Jiangsu Province[J]. Chin J Health Policy,2022,15(7): LI Y,DING J X,LI W,et al. Research on the infusion
38-44. management model of national reimbursement negotiation
[ 5 ] 付瑞枫,茅宁莹. “双通道” 背景下国谈创新药零售终端 drugs under “dual channel” management mechanism[J].
流通现状[J]. 卫生经济研究,2023,40(2):24-27,33. World Clin Drugs,2021,42(9):734-740.
FU R F,MAO N Y. Analysis on the circulation and [13] 韩晓睿,丁锦希,李伟,等. 国家谈判药品“双通道” 的遴
obstacles of innovative drugs in retail terminal under the 选标准与实施路径[J]. 世界临床药物,2021,42(9):
dual-channel policy in China[J]. Health Econ Res,2023, 717-724.
40(2):24-27,33. HAN X R,DING J X,LI W,et al. Research on the selec‐
[ 6 ] SMITH T B. The policy implementation process[J]. tion criteria and implementation path of “dual channel”
Policy Sci,1973,4(2):197-209. management mechanism for national reimbursement nego‐
[ 7 ] 陈庆云 . 公共政策分析[M]. 北京:北京大学出版社, tiation drugs[J]. World Clin Drugs,2021,42(9):717-724.
2006:169. [14] 刘心怡,张璐莹,陈文. 国家谈判药品的医保管理实践案
CHEN Q Y. Public policy analysis[M]. Beijing:Peking 例研究[J]. 中国医疗保险,2021(3):34-37.
University Press,2006:169. LIU X Y,ZHANG L Y,CHEN W. Case studies on the
[ 8 ] 朱文静,褚福浩. 药品“双通道” 机制下定点零售药店执 medical insurance management of national negotiated
业药师作用探讨[J]. 中国药业,2023,32(20):17-20. drugs in China[J]. China Health Insur,2021(3):34-37.
ZHU W J,CHU F H. Discussion on the role of licensed [15] 高学坤,孙言才,虞德才,等. 某三甲专科医院药品冷链
pharmacists in designated retail drugstores under the 自动监控管理系统的建设实践[J]. 中国药房,2018,29
“dual channel” mechanism of drugs[J]. China Pharm, (17):2323-2327.
2023,32(20):17-20. GAO X K,SUN Y C,YU D C,et al. Construction of drug
[ 9 ] 彭瑾,蒋俊男,邱增辉,等. 国家医保谈判药品在浙江省 cold chain automatic monitoring management system in a
三级医疗机构的落地实践[J]. 中国药房,2023,34(10): third grade class A special hospital[J]. China Pharm,2018,
1159-1164. 29(17):2323-2327.
PENG J,JIANG J N,QIU Z H,et al. Landing practices of [16] 杨赐然,王瑞,罗银,等. 国谈药“双通道” 管理政策设计
national medical insurance negotiated drugs in tertiary 的省际比较研究[J]. 中国卫生政策研究,2023,16(4):
medical institutions of Zhejiang Province[J]. China 25-31.
Pharm,2023,34(10):1159-1164. YANG C R,WANG R,LUO Y,et al. Inter-provincial
[10] 张博,丁锦希,陈烨,等. 国家医保谈判药品“双通道” 政 comparative study on the design of “dual-channel” ma-
策动因与实施模式[J]. 世界临床药物,2021,42(9): nagement policies for national health insurance negotiated
709-716. drugs[J]. Chin J Health Policy,2023,16(4):25-31.
ZHANG B,DING J X,CHEN Y,et al. Research on the [17] 南京市医疗保障局 . 线上开方 统一流转 便捷购药! 南
policy motivation and implementation model of “dual 京市医保电子处方流转超 3 万人次[EB/OL].(2023-08-
channel” management mechanism for national reimburse‐ 17)[2023-11-03]. http://ybj. nanjing. gov. cn/gzdt/202308/
ment negotiation drugs[J]. World Clin Drugs,2021,42 t20230817_3989143.html.
(9):709-716. Nanjing Healthcare Security Administration. Online pre‐
[11] 国家药品监督局药品评价中心,国家药品不良反应监测 scription and unified circulation for convenient medicine
中心 . 国家药品不良反应监测年度报告:2022 年[J]. 中 purchase! The circulation of electronic prescriptions for
国药物警戒,2023,20(6):712-719. medical insurance in Nanjing has exceeded 30 000 person-
Center for Drug Reevaluation of NMPA,National Center times[EB/OL].(2023-08-17)[2023-11-03]. http://ybj.nanjing.
for ADR Monitoring of China. National adverse drug reac‐ gov.cn/gzdt/202308/t20230817_3989143.html.
tion monitoring annual report:2022[J]. Chin J Pharmaco‐ (收稿日期:2023-10-18 修回日期:2024-03-21)
vigil,2023,20(6):712-719. (编辑:孙 冰)
[12] 李轶,丁锦希,李伟,等. “双通道” 谈判药品的输注管理
中国药房 2024年第35卷第8期 China Pharmacy 2024 Vol. 35 No. 8 · 911 ·